Singapore markets close in 2 hours 31 minutes
  • Straits Times Index

    3,124.31
    +7.99 (+0.26%)
     
  • Nikkei

    28,455.60
    +528.23 (+1.89%)
     
  • Hang Seng

    23,807.12
    +457.74 (+1.96%)
     
  • FTSE 100

    7,232.28
    +109.96 (+1.54%)
     
  • BTC-USD

    51,056.02
    +2,345.68 (+4.82%)
     
  • CMC Crypto 200

    1,319.15
    +58.99 (+4.68%)
     
  • S&P 500

    4,591.67
    +53.24 (+1.17%)
     
  • Dow

    35,227.03
    +646.95 (+1.87%)
     
  • Nasdaq

    15,225.15
    +139.68 (+0.93%)
     
  • Gold

    1,782.20
    +2.70 (+0.15%)
     
  • Crude Oil

    70.59
    +1.10 (+1.58%)
     
  • 10-Yr Bond

    1.4340
    0.0000 (0.00%)
     
  • FTSE Bursa Malaysia

    1,489.35
    +5.90 (+0.40%)
     
  • Jakarta Composite Index

    6,592.74
    +45.62 (+0.70%)
     
  • PSE Index

    7,113.96
    -16.78 (-0.24%)
     
AIRLINES:

Omicron’s rapid spread shreds budding recovery in air travel

Never Mind Ginkgo Bioworks' Drama -- This Synthetic Biology Stock Is Still a Buy

·3-min read
Never Mind Ginkgo Bioworks' Drama -- This Synthetic Biology Stock Is Still a Buy
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

If the latest short-seller attack on Ginkgo Bioworks has you nervous about synthetic biology, consider the industry leader.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting